|June 6-7, 2017|
SLAS Nordic Chemical Biology Meeting at the University of Copenhagen, Denmark
On the second day of this conference, Steve Rees, Vice-President, Screening Sciences and Sample Management at AstraZeneca, will give a Keynote Lecture on Compound Management and Hit Discovery for the 2020’s. In this presentation he will describe the vision for the UK Centre for Lead Discovery, the technology innovations being implemented in Compound Management and High Throughput Screening to create new capability, and the strategies being adopted to enrich the quality and diversity of the compound library to meet the aspiration of multiple quality hit series for every drug target. He will also briefly reveal the role Specs plays in AstraZeneca outsourced solid compounds collection management now and in the near future.
Meet Yulia Gerhardt, our Business Development Manager Europe, on this conference on the 7th of June. Feel free to arrange a meeting with her upfront via firstname.lastname@example.org
|published on: 30-May-17|